Tennessee Oncology, PLLC
Nashville, Tennessee, 37023, United States
NCT Number: NCT00876408
This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nashville, Tennessee, 37023, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
SCRI Development Innovations, LLC
Other
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer: Role in Clinical Management and Primary Site Prediction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05841966
Cancer of Unknown Primary Site, Carcinoma
Aarhus, Denmark
View Trial DetailsNCT02906943
Breast Cancer, Breast Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT05576974
Carcinoma, Carcinoma, Squamous Cell
Dallas, Texas, United States
View Trial DetailsNCT04584008
Biliary Tract Diseases, Biliary Tract Neoplasms
Beijing, Beijing Municipality, China
View Trial Details